SW
ABBV icon

StrongBox Wealth’s AbbVie ABBV Stock Holding History

StrongBox Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.11M Buy
4,409
+60
+1% +$12.9K 0.32% 50
2026
Q1 		$946K Buy
4,349
+588
+16% +$130K 0.3% 53
2025
Q4 		$859K Buy
3,761
+111
+3% +$25.3K 0.28% 53
2025
Q3 		$845K Sell
3,650
-356
-9% -$72.5K 0.29% 51
2025
Q2 		$744K Buy
4,006
+128
+3% +$23.8K 0.28% 56
2025
Q1 		$813K Sell
3,878
-56
-1% -$10.9K 0.34% 52
2024
Q4 		$699K Sell
3,934
-71
-2% -$13.1K 0.3% 52
2024
Q3 		$791K Buy
4,005
+1,634
+69% +$305K 0.34% 50
2024
Q2 		$407K Buy
2,371
+388
+20% +$64.3K 0.19% 62
2024
Q1 		$361K Sell
1,983
-47
-2% -$8.1K 0.19% 62
2023
Q4 		$315K Buy
2,030
+396
+24% +$57.7K 0.18% 63
2023
Q3 		$244K Sell
1,634
-304
-16% -$44.6K 0.16% 72
2023
Q2 		$261K Sell
1,938
-5,051
-72% -$741K 0.16% 75
2023
Q1 		$1.11M Sell
6,989
-9,066
-56% -$1.39M 0.75% 41
2022
Q4 		$2.59M Sell
16,055
-3,462
-18% -$531K 1.84% 20
2022
Q3 		$2.62M Buy
19,517
+2,696
+16% +$387K 1.9% 18
2022
Q2 		$2.58M Sell
16,821
-1,506
-8% -$230K 1.67% 18
2022
Q1 		$2.97M Sell
18,327
-613
-3% -$89K 1.69% 17
2021
Q4 		$2.56M Buy
18,940
+2,712
+17% +$320K 1.28% 26
2021
Q3 		$1.75M Buy
16,228
+2,051
+14% +$234K 0.98% 39
2021
Q2 		$1.6M Buy
14,177
+1,917
+16% +$216K 0.92% 41
2021
Q1 		$1.33M Buy
12,260
+2,573
+27% +$275K 0.82% 40
2020
Q4 		$1.04M Sell
9,687
-440
-4% -$42.3K 0.67% 42
2020
Q3 		$887K Buy
10,127
+2,192
+28% +$206K 0.65% 40
2020
Q2 		$779K Buy
7,935
+4,214
+113% +$371K 0.71% 43
2020
Q1 		$283K Buy
+3,721
New +$317K 0.32% 65

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

StrongBox Wealth's ABBV Position: Q2 2026 in Review

StrongBox Wealth increased its AbbVie (ABBV) stake by 1.4% in Q2 2026, buying an estimated $12.9K and bringing the position to 4,409 shares worth $1.11M. The position accounts for 0.32% of the portfolio, ranked #50.

StrongBox Wealth first reported a position in ABBV in Q1 2020 and has held it in 26 quarters since. The position peaked at $2.97M in Q1 2022. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • StrongBox Wealth held 4,409 shares of AbbVie worth $1.11M as of Q2 2026.
  • StrongBox Wealth bought 60 AbbVie shares in Q2 2026, an estimated $12.9K.
  • AbbVie made up 0.32% of StrongBox Wealth's portfolio in Q2 2026, its #50 holding.
  • StrongBox Wealth first reported a position in AbbVie in Q1 2020 and has held it in 26 quarters since.
  • StrongBox Wealth's AbbVie position peaked at $2.97M in Q1 2022.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on StrongBox Wealth's 13F filing for Q2 2026, filed 23 Jul 2026.